Doctor profile · Federal record
Dr. Jeffrey Matous, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Denver, CO
- NPI 1992789036
- Accepts Medicare
- MIPS 67.1 / 100 · 2023
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1800 Williams St, Ste 300
Denver, CO 802181238
(720) 754-4800
fax (720) 754-4801 - Mailing address
-
4900 S Monaco St, #210
Denver, CO 802373486
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- February 11, 2014
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Colorado #28753
- Medicaid (6)
- NE #10025893500 · NM #54420288 · WY #1992789036 · CO #01287531 · WY #117674900 · KS #200606940B
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992789036. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,381
Distinct HCPCS
10
Medicare allowed
$527,023
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,560 | 29 | $47 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,540 | 24 | $42 | |
36415 |
Insertion of needle into vein for collection of blood sample | 832 | 133 | $8 | |
J3475 |
Injection, magnesium sulfate, per 500 mg | 324 | 21 | $1 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 290 | 131 | $180 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 192 | 12 | $0 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 131 | 48 | $21 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 102 | 51 | $75 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 79 | 56 | $66 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 76 | 67 | $129 |
In context: peer comparison
Among 15 peers in Denver Hematology & Oncology Physician, average services per provider: 845. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$447
Transactions
15
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 4 | $151.57 | |
| BeiGene USA, INC. | 3 | $125.55 | |
| Abbvie INC. | 4 | $76.62 | |
| Genentech USA, INC. | 1 | $29.20 | |
| Blueprint Medicines Corporation | 1 | $23.24 | |
| Celgene Corporation | 1 | $20.80 | |
| Ipsen Biopharmaceuticals, INC | 1 | $19.61 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
322
Patients
41
Total drug cost
$714,199
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 125 | 28 | $2,088 |
| Brukinsa (Zanubrutinib) | Brand | 47 | 0 | $695,271 |
| Dexamethasone | Generic | 35 | 13 | $637 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 21 | 0 | $1,165 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 18 | 0 | $110 |
| Hydroxyurea | Generic | 17 | 0 | $776 |
| Xarelto (Rivaroxaban) | Brand | 13 | 0 | $9,856 |
| Atorvastatin Calcium | Generic | 12 | 0 | $318 |
| Gabapentin | Generic | 12 | 0 | $101 |
| Cyclophosphamide | Generic | 11 | 0 | $3,642 |
Hospital affiliations
Frequently asked questions
What is Dr. Jeffrey Matous's medical specialty?
Dr. Jeffrey Matous practices Hematology & Oncology Physician in Denver, CO.
Where does Dr. Jeffrey Matous practice?
Dr. Jeffrey Matous practices at 1800 Williams St, Denver, CO 802181238. Office phone: 7207544800.
What is Dr. Jeffrey Matous's NPI?
Dr. Jeffrey Matous's National Provider Identifier (NPI) is 1992789036, issued by NPPES.
Does Dr. Jeffrey Matous accept Medicare assignment?
Yes. Dr. Jeffrey Matous accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Matous commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS J1568); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.